Elsevier

Cancer Epidemiology

Volume 33, Issue 5, November 2009, Pages 315-318
Cancer Epidemiology

Review
Breast cancer as a global health concern

https://doi.org/10.1016/j.canep.2009.10.003Get rights and content

Abstract

Public health data indicate that the global burden of breast cancer in women, measured by incidence, mortality, and economic costs, is substantial and on the increase. Worldwide, it is estimated that more than one million women are diagnosed with breast cancer every year, and more than 410,000 will die from the disease. In low- and middle-income countries (LMCs), the infrastructure and resources for routine screening mammography are often unavailable. In such lower resource settings, breast cancers are commonly diagnosed at late stages, and women may receive inadequate treatment, pain relief, or palliative care. There have been an increasing number of global health initiatives to address breast cancer including efforts by Susan G. Komen for the Cure©, the Breast Health Global Initiative (BHGI), the U.S. Centers for Disease Control and Prevention (CDC), the American Cancer Society, the National Cancer Institute (NCI), and ongoing work by leading oncology societies in different parts of the world. To support such initiatives, and to provide a scientific evidence base for health policy and public health decision making, there is a need for further health services research and program evaluations. Cancer registries can be invaluable in ascertaining the magnitude of cancer disease burden and its distribution in these countries. Additional data are needed for various geographic areas to assess resources required, cost-effectiveness, and humane approaches for preventing or controlling breast cancer in low resource settings in developing countries.

Section snippets

Global initiatives to combat breast cancer

In view of the breast cancer disease burden in LMCs and the fact that these cancers are commonly diagnosed at late stages in low resource settings, there have been an increasing number of global health initiatives to address breast cancer. In 2002, a group of breast cancer experts from around the world, with assistance from the U.S.-based Susan G. Komen for the Cure©, and Fred Hutchison Cancer Research Center helped cofound the Breast Health Global Initiative (BHGI) [12]. The mission of BHGI is

Future directions for research aimed at addressing breast cancer in low- and middle-income countries

To support initiatives such as those spearheaded by BHGI, Susan G. Komen for the Cure, ACS, CDC, NCI, and UICC, and to provide a scientific evidence base for health policy and public health decision making, there is a need for further health services research and program evaluations. Additional evaluation studies focused on health communication and behavioral aspects of breast cancer prevention and control could be undertaken through ICISG. Because of the importance of data for decision making,

Conflict of interest

The authors have no conflicts of interest to report.

References (41)

  • D.M. Parkin et al.

    Use of statistics to assess the global burden of breast cancer

    Breast J

    (2006)
  • B.O. Anderson et al.

    Breast cancer in limited-resource countries: health care systems and public policy

    Breast J

    (2006)
  • B. Stewart et al.

    World Cancer Report

    (2003)
  • IARC handbooks of cancer prevention. Vol. 7: breast cancer screening

    (2002)
  • B.O. Anderson et al.

    Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the breast health global initiative global summit 2007

    Cancer

    (2008)
  • P. Porter

    “Westernizing” women's risks? Breast cancer in lower-income countries

    N Engl J Med

    (2008)
  • S.K. Pal et al.

    Improving cancer care in India: prospects and challenges

    Asian Pac J Cancer Prev.

    (2004)
  • B.O. Anderson et al.

    Overview of breast health care guidelines for countries with limited resources

    Breast J

    (2003)
  • B.O. Anderson et al.

    Early detection of breast cancer in countries with limited resources

    Breast J

    (2003)
  • K.P. Morales et al.

    Compendio del registro histopatologico de neoplasias en Mexico

    (1997)
  • Cited by (418)

    • LCN2: Versatile players in breast cancer

      2024, Biomedicine and Pharmacotherapy
    View all citing articles on Scopus

    The findings and conclusions in this paper are those of the authors and do not necessarily represent the official positions of the Centers for Disease Control and Prevention (CDC) or the Department of Veterans Affairs (VA). The authors gratefully acknowledge assistance provided by Mollie Williams and Susan G. Komen for the Cure.

    View full text